Perceived sexual difficulties and associated factors in patients with heart failure by Hoekstra, Tialda et al.
  
 University of Groningen
Perceived sexual difficulties and associated factors in patients with heart failure






IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from
it. Please check the document version below.
Document Version
Publisher's PDF, also known as Version of record
Publication date:
2012
Link to publication in University of Groningen/UMCG research database
Citation for published version (APA):
Hoekstra, T., Jaarsma, T., Sanderman, R., van Veldhuisen, D. J., & Lesman-Leegte, I. (2012). Perceived
sexual difficulties and associated factors in patients with heart failure. American Heart Journal, 163(2), 246-
251. https://doi.org/10.1016/j.ahj.2011.10.011
Copyright
Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the
author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).
Take-down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the
number of authors shown on this cover page is limited to 10 maximum.
Download date: 12-11-2019
Congestive Heart FailurePerceived sexual difficulties and associated factors in
patients with heart failure
Tialda Hoekstra, MSc, a Tiny Jaarsma, RN, PhD, a,b Robbert Sanderman, PhD, c Dirk J. van Veldhuisen, MD, PhD, a
and Ivonne Lesman-Leegte, RN, PhD a Groningen, The Netherlands; and Norrköping, SwedenBackground Sexual dysfunction is a common problem of increasing incidence in patients with heart failure (HF).
However, there is no knowledge on which demographic, clinical, and quality of life (QoL) aspects are related to difficulties in
sexual activity nor on the course of sexual difficulties in patients with HF.
Methods Data on sexual difficulties were collected at 1 and 18 months after an HF hospitalization (n = 792, mean age
69 ± 12 years, 35% female, mean left ventricular ejection fraction 33% ± 14%) by the question on sexuality of the Minnesota
living with HF questionnaire. Demographic and clinical factors were assessed from medical records and QoL by Minnesota
living with HF questionnaire, Medical Outcome Study 36-item General Health Survey, and Ladder of Life.
Results In total, 48% (n = 380) of the patients perceive difficulties in sexual activity at 1 month after discharge, and 70%
continued to perceive this at 18 months. Furthermore, 27% of the patients without difficulties at 1 month developed them during
follow-up. Living with a partner (OR 3.76, 95% CI 2.58-5.48), younger age (OR 0.96, 95% CI 0.94-0.97)), male gender
(OR 3.08, 95% CI 2.10-4.43), overall well-being (OR 1.13, 95% CI 1.00-1.27), and physical (OR 1.06, 95% CI 1.06-1.08)
and emotional (OR 1.07, 95% CI 1.03-1.10) QoL were independently associated with perceived difficulties in sexual activity.
Conclusions Perceived difficulties in sexual activity are common in patients with HF, particularly in younger and male
patients and continue over time. Patients who perceive difficulties in sexual activity report a significant lower QoL and overall
well-being than those who do not. (Am Heart J 2012;163:246-51.)Heart failure (HF) is a significant health problem
affecting the quality of life (QoL) of patients.1 Patients
with HF have symptoms such as fatigue and shortness of
breath,2 psychologic factors such as depression,1,3 and
low functional capacity,4,5 and they also need to manage
lifestyle changes.6 These factors affect not only overall
QoL but also the intimacy needs of a patient with HF.7
It is often expected that, among seriously ill patients,
sexual activity is not important. However, patients with
HF consider sexual activity in their current condition as
an essential aspect of QoL,8 but symptoms of HF do affect
the sexual relationships of patients with HF.9 At least 50%
of all patients with HF report that their sexual activity has
reduced or completely ceased as a result of their HF.
Furthermore, half of the patients with HF have problems
with sexual activity caused by erectile dysfunction or
orgasmic problems and sexual dissatisfaction.7-10 Therom the aDepartment of Cardiology, University of Groningen, University Medical Center
roningen, The Netherlands, bDepartment of Social- and Welfare Studies, University of
nköping, Norrköping, Sweden, and cHealth Psychology Section, Department of Health
ciences, University of Groningen, University Medical Center Groningen, The Netherlands.
unding Sources: The COACH study was supported by a program grant from the
etherlands Heart Foundation (grant 2000Z003). Prof van Veldhuisen is a Clinical
stablished Investigator of the Netherlands Heart Foundation (grant D97.017).
dditional unrestricted grants were obtained from Biosite Europe, France, Roche
iagnostics, The Netherlands and Novartis Pharma BV, The Netherlands.
Trial register: NCT98675639.
Submitted June 6, 2011; accepted October 26, 2011.
Reprint requests: Tialda Hoekstra, MSc, Department of Cardiology, University of
Groningen, University Medical Center Groningen, PO Box 30.001, 9700 RB Groningen,
The Netherlands.
E-mail: t.hoekstra@thorax.umcg.nl
0002-8703/$ - see front matter









Dcurrent HF guidelines recommend counseling on sexual
activity with both male and female patients and their
partners. The given class of recommendation is I;
however, the level of evidence is C, which indicates
that counseling on sexual activity is suggested to be very
important, but not many studies have focused on this
subject.11 Two small studies examining predictors of
decrease in sexual activity in relatively young and
predominantly male patients with HF show that worse
functional capacity, high New York Heart Association
(NYHA) class, the number of medications, diabetes, as
well as tobacco and alcohol use contribute to a decrease
of sexual activity.7,12 Furthermore, HF therapy with
β-receptor blockers, digoxin, and thiazide is known to
worsen sexual activity.13 However, it is not known
whether these variables are also related to difficulties in
sexual activity in an older HF population or specifically in
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patients without a partner are lacking.
Knowledge on the relationship between difficulties
with sexuality and QoL is based on a few smaller studies
in specific HF study populations and shows that better
sexual function is related to a higher overall well-being.9
To appropriately address the importance and effects of
difficulties in sexual activity in the lives of all patients
with HF, including women and elderly, more informa-
tion is needed on the relationship between QoL and
sexual problems.
Although there is a recent growing interest in reporting
data on sexual problems of patients with HF, current
studies have a cross-sectional design without providing
insight in sexual problems over time. In case of sexual
problems that are assessed at hospital discharge, clini-
cians may assume that these will disappear spontaneously
during recovery. In general, there is little follow-up on the
course of sexual activity during the trajectory of HF. Only
one small study reported that both at discharge and at 9
months after discharge, patients with HF reported
problems and sexual concerns. However, this study did
not report the development of new cases or recovered
patients during this period of time.9
To gain more insight in sexual problems in patients
with HF, the following research questions were formu-
lated to study in a large representative population of
patients with HF:
1. Which demographic and clinical variables are
related to difficulties in sexual activity?
2. Which QoL aspects are independently related to
difficulties in sexual activity?




Data of patients participating in the Coordinating study
evaluating Advising and Counselling in Heart failure (COACH)
study were used. The COACH study is a multicenter, random-
ized clinical trial on the effect of education and counseling in
HF.14,15 Between November 2002 and February 2005, 1,023
patients from 17 Dutch hospitals were included in the COACH
study. Patients were included in the study during admission for
HF (NYHA functional class II to IV), with HF as the primary
diagnosis as confirmed by a cardiologist. During hospitalization,
patients were randomized to (1) basic support, (2) intensive
support, or (3) control treatment. Patients were 18 years or
older and had evidence of structural underlying heart disease as
shown at cardiovascular imaging. Reasons for exclusion were as
follows: concurrent inclusion in a study requiring additional
visits to health care personnel, restrictions that made the patient
unable to fill in data collection forms, invasive intervention
within the last 6 months or planned during the following 3
months, or ongoing evaluation for heart transplantation. All
patients gave written informed consent. Patients completedquestionnaires and were interviewed by an independent
interviewer not involved in care for these patients. All patients
were treated from hospital discharge until 18 months after
hospital discharge.
The study that was performed conform the principles
outlined in the Declaration of Helsinki and was approved by
the Committee for Ethics in Medical Investigations.Data collection
Difficulties with sexual activity. Data on sexual
activity in the COACH study were collected during index
hospitalization and follow-up. To minimize the confounding
effect of the recent hospitalization on sexual activity, we used the
data on sexual activity at 1 month after discharge. Sexual activity
was assessed by the following question of the Minnesota Living
with Heart Failure (MLwHF) questionnaire16: “Did your heart
failure prevent you from living as you wanted during the past
month by making your sexual activities difficult?” Scoring format
consists of 0 (no difficulties in sexual activity) and 1 to 5 (very
little to very much difficulties). For the “course of difficulties in
sexual activity,” data at 1 and 18 months after discharge were
used. Four groups were created based on the scores at the 2
different time points: continued difficulties (at 1 and 18 months
difficulties with sexuality), new-onset difficulties (no problems at
1 month and problems at 18 months), recovered difficulties
(problems at 1 month but not at 18 months), and no difficulties
(at 1 and 18 months). Data on sexual activity were also collected
at 6 and 12 months after discharge. These data were analyzed as
well; however, results do not differ from the current results at 18
months after discharge. For reasons of readability, it was decided
not to include these results.
Demographic and clinical characteristics. Data on
demographic and clinical characteristics were collected from
chart review, interviews, and questionnaires. Depressive
symptoms were measured with the Center for Epidemiological
Studies Depression scale (CES-D), a 20-item self-report question-
naire designed to measure depressive symptoms in the general
population and has been widely used with the medically ill. A
total sum score is used (0-60), with higher scores indicating
more depressive symptoms.17,18
Functional capacity was measured by the 6-minute walking
test (6MWT) on a predefined course. Patients were instructed to
walk as many meters as they could within 6 minutes. At
standardized moments, the instructor told the patients the
amount of time remaining. Patients were allowed to stop or slow
down if necessary. The 6MWT is a reliable and well-validated
test for functional capacity in patients with HF.19
Quality of life. Data on QoL were collected using several
questionnaires completed at 1 month after discharge. Disease-
specific QoL was measured with the MLwHF questionnaire,16 a
21-item questionnaire assessing how HF has affected the life of
the respondent during the last month. The questions cover
symptoms and signs relevant to HF such as physical activity,
social interaction, sexual activity, work, and emotions. Three
scores can be determined: an overall score (21 items, 0-105), the
physical dimension (8 items, 0-40), and the emotional dimension
(5 items, 0-25). Higher scores mean worse QoL. The item on
sexual functioning is in neither one of both dimensions;
however, it is part of the total score. Therefore, the total score
was excluded from the analyses.






PPercentage or mean ± SD
Demographics
Gender (female) 46 24 b.001






Care as usual 33% 33%
Basic support 32% 34%
Intensive support 36% 33%
NYHA III-IV 46 48 .514
LVEF (%) 35 ± 15 32 ± 14 .007







Hypertension 44 40 .329
Diabetes 29 24 .100
COPD 25 26 .743
BNP (pg/mL),
median (IQR)
400 (180-808) 427 (194-888) .272
BMI 27 ± 5 27 ± 5 .244
Smoking 11 14 .339
Length of
disease (y)
2.6 ± 4.5 2.4 ± 3.8 .131
CES-D (discharge) 15 ± 11 16 ± 11 .035
6MWT
distance (m)











COPD, Chronic obstructive pulmonary disease; BNP, B-type natriuretic peptide; IQR,
interquartile range; BMI, body mass index.
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is a single-item measure that asks to rate the sense of well-being
on a ladder, with 10 reflecting the best possible life imaginable
and 0 reflecting the worst possible life imaginable. A higher
score indicates better well-being.20
General QoL was assessed by the Medical Outcome Study 36-
item General Health Survey (RAND-36), a self-report question-
naire of general health status. It is a well-validated generic, 36-
item questionnaire that includes 9 health concepts that
represent dimensions of QoL: physical functioning, social
functioning, role limitations because of physical functioning,
role limitations because of emotional functioning, mental health,
vitality, bodily pain, general health, and perceived health
change. Each dimension has a score between 0 and 100; a
higher score means better QoL.21
Statistical analysis
Data are presented as mean ± SD or as percentages unless
stated otherwise. Univariate analyses were carried out by using
Mann-Whitney U for continues or χ2 for categorical variables.
Logistic regression analysis was performed to assess which
demographic and clinical variables were independently associ-
ated with difficulties in sexual activity. Difficulties in sexual
activity was used as the dependent variable. Based on univariate
differences with P b .10, the following variables were inserted in
the regression model, using backward methods: gender, age,
living with a partner, left ventricular ejection fraction (LVEF),
CES-D, 6MWT, angiotensin-converting enzyme (ACE)/angioten-
sin receptor blocker (ARB), diuretics, Ladder of life, MLwHF
physical and emotional dimensions, and the following di-
mensions of the RAND-36: social functioning, physical role
limitations, emotional role limitations, mental health, vitality,
bodily pain, and general health. Student t tests were carried out
to compare the change in the independently associated QoL
scores (score at 18 months minus score at 1 month after
discharge) and the number of hospital admissions between new-
onset patients and patients with no difficulties.
Analyses were performed using SPSS 16 (SPSS Inc,
Chicago, IL). Outcomes were considered statistically signifi-
cant when P b .05.
The COACH study was supported by a program grant from the
Netherlands Heart Foundation (grant 2000Z003). Additional
unrestricted grants for the main COACH study were obtained
from Biosite Europe, France, Roche Diagnostics, The Nether-
lands and Novartis Pharma BV, The Netherlands. The authors are
solely responsible for the design and conduct of this study, all




Of the 1,023 patients included in the COACH study, 44
died within 1 month after discharge. Of the survivors, 792
(81%) patients completed the question about sexuality of
the MLwHF questionnaire at 1 month after discharge
(mean age 69 ± 12 years, 35% female, mean LVEF 33% ±
14%). The 187 patients who did not complete this
question were significantly more often female, older,
living without a partner, in NYHA III to IV at discharge,
diagnosed with diabetes, had a higher LVEF, and walkedless far on the 6MWT. Of the 187 patients who survived
the follow-up at 1 month after discharge, but specifically
did not complete the question on sexual difficulty, 51
patients did fill out the rest of the MLwHF questionnaire.
At 18 months after discharge, 638 (81%) of the 792
patients were alive, and 555 (87%) patients completed
the question on sexual activity both at 1 and 18 months
after discharge.
Difficulties with sexual activity
Of the 792 patients, 380 (48%) reported difficulties in
sexual activity at 1 month after discharge. Almost half of
these patients (n = 186) reported considerable difficulties,
they reported that HF prevented them very much of living
as they wanted by making their sexual activities difficult.
Table II. Quality of life scores of patients with and without





PMean scores ± SD
Ladder of life 6.4 ± 1.6 6.2 ± 1.6 .068
Minnesota living with HF
Physical dimension 17 ± 11 23 ± 11 b.001
Emotional
dimension
6 ± 6 9 ± 6 b.001
RAND-36—Physical
functioning
44 ± 28 41 ± 26 .152
RAND-36—social
functioning
61 ± 30 52 ± 29 b.001
RAND-36—role
lim. physical
26 ± 37 15 ± 30 b.001
RAND-36—role
lim. emotional
54 ± 46 41 ± 45 b.001
RAND-36—mental
health
72 ± 20 67 ± 21 .002
RAND-36—vitality 51 ± 23 44 ± 22 b.001
RAND-36—bodily
pain
75 ± 28 72 ± 29 .066
RAND-36—general
health
46 ± 20 42 ± 18 .008
RAND-36—health
change
35 ± 28 33 ± 31 .173
Table III. Adjusted associations between patients with and
without difficulties in sexual activity
ariables B (SE)
95% Cl for OR
POR Lower Upper
ge −.04 (0.01) .96 .94 .97 b.001
ender (male) 1.13 (0.20) 3.08 2.10 4.43 b.001








−.06 (0.00) 1.07 1.03 1.10 b.001
adder of life .12 (0.06) 1.13 1.00 1.27 .049
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Volume 163, Number 2Patients with HF who perceive sexual difficulties were
more often male (76% vs 54%, P b .001), younger of age
(66 vs 72 years old, P b .001) and more often living with a
partner (82% vs 49%, P b .001), had a lower LVEF (32% vs
35%, P = .007), had higher score on a depression scale
(16 vs 15, P = .035), and walked further on the 6MWT
(272 vs 244 minutes, P = .013) (Table I). At hospital
discharge, more patients reporting sexual difficulties had
a prescription of ACE/ARB (88% vs 83%, P = .019). No
differences were found regarding β-blocker use and the
assigned COACH intervention.
Patients with sexual difficulties had significant lower
QoL compared with patients without sexual difficulties
on both the physical and emotional dimensions of the
MLwHF questionnaire (23 vs 17 and 9 vs 6, P b .001,
Table II). Of 9 dimensions of the RAND-36, 6 differed
significantly between the patients with and without
difficulties in sexual activity. Patients who perceive
difficulties had significant lower QoL scores on social
functioning, physical and emotional role limitations,
mental health, vitality, and general health.
In multivariate analyses, living with a partner (OR 3.76,
95% CI 2.58-5.48), younger age (OR 0.96, 95% CI 0.94-
0.97)), male gender (OR 3.08, 95% CI 2.10-4.43), overall
well-being (OR 1.13, 95% CI 1.00-1.27), and physical (OR
1.06, 95% CI 1.06-1.08) and emotional (OR 1.07, 95% CI
1.03-1.10) QoL were independently associated with
difficulties in sexual activity caused by HF that prevented






LCourse of difficulties in sexual activity
At 1 month after discharge, 270 of the 555 patients
(49%) reported difficulties in sexual activity, and at 18
months after discharge, 268 (48%) patients reported
difficulties in sexual activity in some degree. Analyses
over time show that, of the 270 patients who reported
sexual difficulties at 1 month after discharge, 80 patients
(30%) recovered at 18 months follow-up and 190 (70%)
patients still reported difficulties. Of the 285 patients who
did not report sexual difficulties at baseline, 207 (73%)
did not report difficulties at 18 months as well, and 78
(27%) developed difficulties during 18 months of follow-
up (new-onset difficulties) (Figure 1). Compared with
patients without difficulties, patients who developed
sexual difficulties were more often male (55% vs 78%, P b
.001) and living with a partner (44% vs 74%, P b .001).
Furthermore, patients who remained without difficulties
improved in QoL over time compared with new-onset
patients whose QoL scores did not change or worsened
(change scores physical QoL: −3.5 vs 0.9, P = .001;
change scores emotional QoL: −2.2 vs 0.04, P = .002;
changes scores well-being: 0.42 vs −0.01, P = .047). The
number of hospital admissions did not differ between
both groups (0.24 vs 0.32, P = .376).Discussion
To our knowledge, this is the first study to explore the
relationship between perceived difficulties in sexual
activity caused by HF and a considerable number of
demographic variables, clinical variables, and QoL
aspects and reports the course of difficulties in sexual
activity, in a representative population of patients with
HF. Almost 50% of patients with HF perceive difficulties
in sexual activity because of their disease, and most (70%)
of these patients continued to report difficulties after an
18-month recovery period. This was a remarkable
difference with perceived difficulties experienced by
20% to 30% of healthy older people.22
Figure 1
Flowchart of patients and course of perceived difficulties in
sexual activity.
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were independently associated with perceived sexual
difficulties. Patients who reported difficulties in sexual
activity had significant lower disease-specific QoL and
overall well-being compared with patients who did not
perceive sexual difficulties. We did not find an indepen-
dent relation of difficulties in sexual activity to disease
severity markers such as NYHA, LVEF or B-type natriuretic
peptide, or β-blocker use. In addition, the use of tobacco
or alcohol, having diabetes, and number of medications, as
described in other studies, were not found to be related to
sexual activity,9,12 possibly because of an older and larger
study population.
We believe that the present analysis is clinically
relevant and extends previous studies by using a large
group of older male and female patients with HF.
Previous studies assessing the relationship between
patient characteristics and sexual functioning used small
and predominantly male patient groups.9,12
Our study is also unique in the sense that we chose to
include both patients with and without a partner. Of
course, we realize that having a partner is strongly
associated with the perception of sexual problems
because patients who have a partner can be expected
to be confronted more often with those problems as part
of their daily life.23 However, our study also showed that
18% of the patients who perceived difficulties with sexual
activity were living without a partner; thus, not only
patients with a partner experience sexual difficulties
caused by HF that prevent them from living as they want.
It is important to report the prevalence in dysfunction in
both patients with and without a partner because patients
might define sexual activity broader than having inter-
course (eg, masturbation) and single patients might
worry about their (future) sex life. The second strongest
variable related to difficulties in sexual activity was male
gender. Of the patients who perceived difficulties insexual activity, 76% was male. Endothelial dysfunction is
prevalent in patients with HF and one of the main
common denominators for erectile dysfunction, but not
in female sexuality.8,24 Therefore, problems in sexuality
can be assumed to affect the male sexual function more
than female sexual function. Although previous research
mainly focused on male sexuality and erectile dysfunc-
tion,8 our study shows that 24% of the patients who
perceive difficulties in sexual activity are women. Heart
failure symptoms such as dyspnea, fatigue, and exercise
intolerance can be assumed to affect sexuality in both
male and female patients.
We rather uniquely report on the course of perceived
difficulties with sexual activities. We found that, at both
time points, approximately half of the patients reported
difficulties with sexual activities caused by symptoms of
HF. However, we also demonstrated that 30% of the
patients, who reported difficulties at 1 month after
discharge, did not report difficulties in sexual activity at
follow-up. Possible reasons for the decrease in difficulties
might be stabilization of HF, increased physical capacity
during recovery, or possible use of PDE5 inhibitors.
However, at the same time, we found that 27% of the
patients without difficulties at 1 month after discharge did
perceive sexual problems at 18 months follow-up and
that, in 70% of the patients with difficulties, these
difficulties remained. Patientswho continue to bewithout
difficulties improved in QoL over time, in contrast to new-
onset patients, whose QoL stayed the same or worsened.
These findings emphasize that sexual concerns need to be
discussed more than once during treatment and should
become an integral part of HF management and patient
education.25,26 It is known that, although most of the
health care providers feel a responsibility to discuss sexual
concerns with their patients, many do not address these
concerns in their daily practice.27,28
Several limitations of this study should be considered.
First, perceiving difficulties in sexual activity was based
on a single question from a larger QoL questionnaire.
This results in a global measurement of difficulties in
sexual activity. However, our results are comparable
with studies that used more extensive questionnaires on
sexual functioning.9 Second, the specific question on
sexual activity concerns perceived difficulties with
sexuality because of HF and that prevents them from
living as they want. We do not know if these patients
actually have sexual problems, we only know that their
HF affects their sexuality. Sexuality activity could, for
example, be affected by HF symptoms such as fatigue or
dyspnea, which is not stated as an actual sexual
problem. Therefore, we do not know if these patients
actually have sexual problems, for example, problems
with erection, or that other factors, such as HF
symptoms, make their sexual activities difficult and
prevent them from living as they want. When interpret-
ing the results, it should also be taken into account that
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partner, and younger of age actually have more
difficulties in sexuality. It can be expected that these
characteristics are associated with a higher likelihood of
reporting difficulties with sexual activities that prevent
the person from living as he/she wants. Finally, our
findings show that difficulties in sexual activity are
related to QoL. Our data do not provide insight in the
cause and effect in this relationship. Patients with
difficulties in sexual activity can be expected to have a
lower QoL because of these difficulties. However, one
can also imagine that a worse QoL can influence sexual
relations because of functional impairment and emo-
tional problems.
This study provides an important step toward under-
standing the occurrence of sexual problems in patients
with HF. Perceiving difficulties in sexual activity caused
by HF and preventing patients from living as they wanted
affect many patients with HF. Furthermore, these
difficulties continue over time and influence the QoL of
these patients. Therefore, it is of great importance to
counsel patients with HF repeatedly on sexual activity
during their treatment.
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